11-67644822-C-T
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_080658.2(ACY3):c.682G>A(p.Val228Ile) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000393 in 1,579,238 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 16/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_080658.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ACY3 | NM_080658.2 | c.682G>A | p.Val228Ile | missense_variant | 7/8 | ENST00000255082.8 | NP_542389.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ACY3 | ENST00000255082.8 | c.682G>A | p.Val228Ile | missense_variant | 7/8 | 1 | NM_080658.2 | ENSP00000255082.3 | ||
ACY3 | ENST00000529256.1 | c.319G>A | p.Val107Ile | missense_variant | 6/7 | 3 | ENSP00000434270.1 |
Frequencies
GnomAD3 genomes AF: 0.0000394 AC: 6AN: 152142Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000513 AC: 10AN: 195066Hom.: 0 AF XY: 0.0000476 AC XY: 5AN XY: 105126
GnomAD4 exome AF: 0.0000392 AC: 56AN: 1426978Hom.: 0 Cov.: 35 AF XY: 0.0000396 AC XY: 28AN XY: 707068
GnomAD4 genome AF: 0.0000394 AC: 6AN: 152260Hom.: 0 Cov.: 33 AF XY: 0.0000269 AC XY: 2AN XY: 74444
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | May 09, 2023 | The c.682G>A (p.V228I) alteration is located in exon 7 (coding exon 5) of the ACY3 gene. This alteration results from a G to A substitution at nucleotide position 682, causing the valine (V) at amino acid position 228 to be replaced by an isoleucine (I). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at